Search arXivSearch

arXiv · 2401.13960

Temperature Compensation through Kinetic Regulation in Biochemical Oscillators

Abstract

Nearly all circadian clocks maintain a period that is insensitive to temperature changes, a phenomenon known as temperature compensation (TC). Yet, it is unclear whether there is any common feature among different systems that exhibit TC. From a general timescale invariance, we show that TC relies on existence of certain period-lengthening reactions wherein the period of the system increases strongly with the rates in these reactions. By studying several generic oscillator models, we show that this counter-intuitive dependence is nonetheless a common feature of oscillators in the nonlinear (far-from-onset) regime where the oscillation can be separated into fast and slow phases. The increase of the period with the period-lengthening reaction rates occurs when the amplitude of the slow phase in the oscillation increases with these rates while the progression-speed in the slow phase is controlled by other rates of the system. The positive dependence of the period on the period-lengthening rates balances its inverse dependence on other kinetic rates in the system, which gives rise to robust TC in a wide range of parameters. We demonstrate the existence of such period-lengthening reactions and their relevance for TC in all four model systems we considered. Theoretical results for a model of the Kai system are supported by experimental data. A study of the energy dissipation also shows that better TC performance requires higher energy consumption. Our study unveils a general mechanism by which a biochemical oscillator achieves TC by operating at regimes far from the onset where period-lengthening reactions exist.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Haochen Fu, Chenyi Fei, Qi Ouyang, Yuhai Tu. 2024-01-25. Temperature Compensation through Kinetic Regulation in Biochemical Oscillators. https://arxiv.org/abs/2401.13960

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

Mapping disease-regulatory flux through eQTL-based causal gene networks: a complex-trait framework applied to coronary artery disease

A substantial proportion of inherited susceptibility to common diseases is mediated through tissue-specific regulatory variation. The omnigenic model hypothesizes that much of this risk arises from distant (trans) regulatory effects that are propagated via gene-regulatory networks (GRNs) from numerous regulatory genes onto a relatively small set of core genes. Two major challenges have hindered an empirical assessment of this model. First, transcriptome-wide association studies primarily assess gene expression that is regulated locally (in cis), and thus miss trans-acting effects. Second, trans regulation has so far been examined only in aggregate, without identifying which regulatory genes transmit disease-associated signals to which target genes. Here, we present a framework that decomposes each gene's disease association into a local cis component and a set of trans components attributable to its upstream regulators, propagated along a directed causal GRN. For each gene, we estimate sparse Bayesian expression models and we assess model performance using out-of-sample prediction. Propagating trans signals through the inferred network yields a disease-regulatory flux map: a directed, signed representation that quantifies the contribution of each regulator to the disease association of each target gene. Applying this framework to seven tissues relevant to coronary artery disease, we demonstrate how genetic variation flows through the GRN to affect disease risk. Outgoing regulatory influences from individual genes are directionally heterogeneous, whereas disease-associated genes tend to integrate convergent input from multiple regulators; these convergent targets are enriched for cardiovascular-related biological processes. Consequently, each gene's disease association can be reinterpreted as a detailed allocation of the disease signal among its contributing regulators.

q-bio.MN

Local energetic coupling enhances the expressivity of chemical computation

Living systems compute with chemistry by mapping environmental signals onto specific internal chemical states. Despite recent advances in molecular programming, it remains unclear which physicochemical features control the computational expressivity of chemical systems. Here we inverse-design thermodynamically consistent chemical reaction networks whose steady-state response to an environmental input computes a target nonlinear function. Using implicit differentiation we train the free-energy landscape directly: standard chemical potentials, transition-state energies and thermodynamic drives. Increasingly large networks generated by elementary ligation and cleavage steps fit increasingly complex nonmonotonic polynomial functions, with expressivity scaling logarithmically with network size, predicted primarily by the number of reactions. Training individual energetic parameter classes reveals that internal thermodynamic drives, capable of breaking detailed balance, dominate trainability, with comparable performances achieved only by pairs of parameter classes. These results identify nonequilibrium drive as the most effective single resource for steady-state computational expressivity in chemical reaction networks.

q-bio.MN

Orchestra: Corroboration-Based Regulatory Candidate Discovery via Composed Bioinformatics MCP Agents

Orchestra composes two independently built bioinformatics MCP servers -- RegNetAgents, which infers gene regulatory network topology from ARACNe networks, and CASCADE, which supplies four independent evidence sources (LINCS knockdown, DepMap essentiality, super-enhancer status, DoRothEA transcription-factor confidence) -- into one multi-agent workflow exposed via the Model Context Protocol. Its central architectural claim is that requiring RegNetAgents' topology evidence and CASCADE's experimental evidence to agree on a candidate regulator yields a more trustworthy candidate than either alone -- not previously tested directly, since RegNetAgents' own validation asked only whether its candidate lists beat chance. We test this on the TCGA tumor-acquired regulator tier (regulators in a gene's tumor ARACNe network but absent from the GREmLN population-averaged baseline), selecting candidates by ARACNe mutual-information (MI) edge weight. On RegNetAgents' published BRCA/COAD focal-gene panel plus matched negative controls, agreement among at least 2 of the 4 CASCADE sources predicts OncoKB cancer-gene status among focal genes (odds ratio 2.89, Benjamini-Hochberg-adjusted p=0.0166) but not among negative controls (p=0.0721); a single source is not diagnostic for either group. The pattern replicates and strengthens in a third cancer type, STAD, on a separately constructed panel (odds ratio 5.82), and against an independently curated ground truth (the Sanger COSMIC Cancer Gene Census). MI edge weight is the strongest single predictor overall (p=0.0003); a logistic-regression likelihood-ratio test confirms corroboration adds value beyond it in both panels (p=0.0234; p=0.0001). Every experiment invokes Orchestra's real agentic entry point.

q-bio.MN